What's the price predictions for safx with its news today
3/11/2026 01:28am
**Short answer:** Today’s news is *directionally positive on fundamentals* (more funding, plant progress, merger talks still alive) but also **very dilutive**. From here, SAFX is still a high‑volatility lottery ticket. Over the next ~30 days, a **reasonable base case is a very wide range roughly between $0.15 and $0.35**, with **no strong evidence** that this headline alone makes a sustained move much higher the “default” outcome.
---
## 1️⃣ What today’s news actually changes
From the press release:
- Stockholders **approved issuing ≥19.99% of the company’s common stock to a single investor (EEME)**, removing the “Share Cap” that previously blocked that.
- This lets EEME finish a **$10M equity investment** into SAFX to fund the Reno plant conversion:
- EEME had **already bought 38M shares for $3.8M**.
- They’re expected to buy **another 62M shares for $6.2M in two tranches later in March**.
⇒ Implied issue price is about **$0.10 per share**.
- The money is earmarked to **upgrade the New Rise Renewables Reno facility** for SAF production using Axens’ Vegan technology.
- The **DevvStream / Southern / EEME business combination is still only at “binding term sheet” stage** – the press release repeats that the deal **may not close** and lists a long list of risks (regulatory approvals, financing, bond issuance, Nasdaq compliance, etc.).
**Net effect of the news:**
- **Bullish side:**
- Reduces near‑term *financing risk* by moving the $10M equity funding toward completion.
- Shows real progress on plant conversion and keeps the multi‑party SAF platform story alive.
- **Bearish side:**
- Confirms **large dilution at ~\$0.10**, well below the current share price.
- Adds a **big new shareholder overhang** (100M+ shares tied to EEME) that could pressure the stock if/when they ever sell.
- The **“$3B EV / $1B+ revenue” type language is still just management aspiration**, not a de‑risked path.
So fundamentally, this is **“good news that comes at a cost”**: better funded, but with a cheap private placement underneath the current market price.
---
## 2️⃣ Where SAFX sits right now
### Price & trend
Using the latest data:
- **Last close:** about **$0.28** on 2026‑03‑10.
- **30‑day trading range:** roughly **$0.15 – $0.32**.
- Over the past ~4 months it **collapsed from the ~$0.80 area to sub‑$0.20**, then bounced back into the high‑$0.20s. The big picture is still a **downtrend with violent rallies**.
Here’s the recent price action plus a statistical median forecast path (not a hard prediction, just what a simple volatility‑based model spits out):
```reference
[{"id":5,"type":"plotly-json"}]
```
### Quant signals (from our factor models)
- **Fundamentals:** Overall rating **“Underperform.”** Most valuation / profitability factors screen **weak vs peers**, with only cash‑to‑market‑cap looking modestly supportive.
- **Technicals:** Overall **“neutral.”** Recent candles include both long upper/lower shadows and a **Piercing Pattern** (historically a bullish reversal pattern), but given how thinly traded SAFX is, these candlestick signals are noisy.
- **Flows:** Overall **“neutral.”** The recent pattern of extra‑large and large order flows has *historically* been followed by **slightly negative average 5‑day returns** in similar setups, with low win rates.
Add to that:
- Annualized volatility from recent data is **well over 200%** – this is **penny‑stock level risk**.
- The private placement price (~**$0.10**) now acts as a **psychological “funding anchor”** below the market.
---
## 3️⃣ 30‑day price scenarios (with today’s news)
Using the last ~60 trading days of returns, I ran a 30‑day Monte‑Carlo simulation (20,000 paths). Statistically, from a starting point near **$0.28**:
- **Median path after 30 days** clusters around **~$0.12–$0.15**.
- **Wide 90% band** runs from roughly **$0.03 on the low end to ~$0.55 on the high end**.
Given how extreme that is, it’s better to think in **scenarios** rather than exact numbers:
### Scenario A – Dilution & gravity toward the raise price (base case)
- Market focuses on:
- Cheap private placement at **$0.10**,
- Large new share issuance,
- Deal still only at term‑sheet stage.
- As new shares come in and the headline fades, **price drifts back toward the mid‑teens to low‑$0.20s**, with spikes on any extra press releases.
- **Roughly:** stock spends most of the time in **$0.15–$0.25** over the next month.
### Scenario B – Story catch‑on / momentum extension
- Retail momentum traders lean into the **“first multi‑pathway SAF platform”** narrative and see the EEME funding as strong validation.
- If a **definitive merger agreement** or further positive plant news hits soon, a squeeze toward **$0.35–$0.50+** is very possible – microcaps can overshoot easily.
- But this requires **more good news on top of today**, not just today’s PR.
### Scenario C – Risk‑off or deal disappointment
- If:
- There’s any **delay / wobble in the business combination**,
- General risk sentiment sours, or
- The company has to lean on *additional* dilutive funding,
- The market may start to treat **$0.10 as the “real” reference value**, dragging SAFX down toward or even below that level.
- In that scenario, **sub‑$0.15** (and test of the financing price) is very plausible.
Putting it bluntly: **today’s news doesn’t magically make SAFX a stable uptrend.** It just shifts the balance slightly away from “financing failure” and toward “funded but heavily diluted continuation of a very speculative story.”
---
## 4️⃣ How to use this, practically
For your style (you’ve been treating SAFX as a speculative, event‑driven trade):
- **Key reference levels:**
- **~$0.10** – implied placement price and a rough “funding floor” if everything goes right.
- **~$0.30–$0.35** – near‑term resistance zone where the last bounce is stalling and where profit‑taking risk is high.
- **Time horizon:**
- **Intraday / 1–3 day trade:** Expect **violent whipsaws** around the headline as the market decides whether this is “big progress” or “another dilutive step.” Position size should be tiny relative to your portfolio.
- **1–4 week swing:** Base case is **chop inside roughly $0.15–$0.35** unless we get a *new* catalyst (definitive merger docs, concrete bond progress, clearer path to Nasdaq compliance).
- **Risk management:**
- Treat this as **purely speculative capital**.
- Respect liquidity: getting in is easy; getting out in size during a selloff might not be.
- Be wary of anchoring on the upside projections ($1B revenue / $3B EV) in the press release – they are explicitly labeled as **forward‑looking and highly uncertain**.
---
If you had to choose *one* main time frame for this – are you trying to catch a **short‑term move off today’s PR** (days), or are you considering a **1–3 month position around the merger / plant‑conversion story**? That’ll change how tight the levels and stops should be.